InsidersTradesSigma
Explore the detailed record of transactions filed by Hilde Steineger, Chief Executive Officer. Officer active across 2 companies, notably Cantargia AB. In total, 2 reports have been published. The latest transaction was filed on 25 March 2026 — Purchase. Regulator: FIN-FSA. The full history is openly available.
2 of 2 declarations
Hilde Steineger is the Chief Executive Officer of Cantargia AB. She is responsible for the strategic and operational direction of the company, focusing on innovation in the biotechnology field. Hilde leverages her expertise to guide the company in developing new treatments and solutions. Her leadership is essential in achieving Cantargia's objectives.